Jason Politi is the chief technical operations officer at Verve Therapeutics. Jason brings over 25 years of industry experience in development, manufacturing, and project management. Jason previously served as senior vice president of technical operations at Verve since 2021. Prior to joining Verve, he served as senior vice president, technical operations at Prevail Therapeutics, where he helped to build and lead the chemistry, manufacturing and controls (CMC) team and managed the company’s AAV gene therapy programs. He was instrumental in the approval of Prevail’s first three investigational new drug applications with the FDA and the supply for Prevail’s clinical trials prior to the company’s acquisition by Eli Lilly in 2021. Before Prevail, Jason served as senior director, clinical manufacturing at Alexion. Earlier in his career, he held leadership roles at various biotechnology and pharmaceutical companies, including Dyax, Biogen and AbbVie. 

Jason holds a B.S. in Chemical Engineering from the Massachusetts’s Institute of Technology and an MBA from Boston College.